Inhibition of macrophage nuclear factor-κB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo

American Journal of Pathology

Volumn 167, Issue 1, 2005, Pages 27-37

  Wilson, Heather M ^a   Chettibi, Salah ^b   Jobin, Christian ^c   Walbaum, David ^a   Rees, Andrew J ^a   Kluth, David C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b GE HEALTHCARE   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FLUORESCENCE; GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; IN VIVO STUDY; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENAL ARTERY; SIGNAL TRANSDUCTION; VIRUS RECOMBINANT;

EID: 21244475215     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62950-1     Document Type: Article

References (41)

1. Nikolic-Paterson DJ, Lan HY, Atkins RC: Macrophages in immune renal injury. Immunologic Renal Diseases. Edited by EG Neilson, WG Couser. Philadelphia, Lippincott-Raven, 1997, pp 575-592
2. Kluth DC, Erwig LP, Rees AJ: Multiple facets of macrophages in renal injury. Kidney Int 2004, 66:542-557
3. Erwig LP, Stewart K, Rees AJ: Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines Am J Pathol 2000, 156:295-301
4. Ikezumi Y, Atkins RC, Nikolic-Paterson DJ: Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J Am Soc Nephrol 2003, 14:888-898
5. Ikezumi Y, Hurst LA, Atkins RC, Nikolic-Paterson DJ: Macrophage-mediated renal injury is dependent on signaling via the JNK pathway. J Am Soc Nephrol 2004, 15:1775-1784
6. Tam FW, Smith J, Cashman SJ, Wang Y, Thompson EM, Rees AJ: Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis. Am J Pathol 1994, 145:126-136
7. Chadban SJ, Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ: Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats. Kidney Int 1997, 51:1809-1817
8. Kluth DC, Ainslie CV, Pearce WP, Clarke D, Anegon I, Rees AJ: Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J Immunol 2001, 166:4728-4736
9. Wilson HM, Stewart K, Brown PAJ, Anegon I, Chettibi S, Rees AJ, Kluth DC: Bone marrow derived macrophages (BMDM) genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther 2002, 6:710-717
10. Teder P, Vandivier RW, Jiang D, Liang J, Conn L, Pure E, Henson PM, Noble PW: Resolution of lung inflammation by CD44. Science 2002, 296:155-158
11. Nagaoka T, Kaburagi Y, Hamaguchi Y, Hasegawa M, Takehara K, Steeber DA, Tedder TF, Sato S: Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol 2000, 157:237-247
12. Flavell RA: The relationship of inflammation and initiation of autoimmune disease: role of TNF super family members. Curr Top Microbiol Immunol 2002, 266:1-9
13. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35
14. Mosser DM: The many faces of macrophage activation. J Leuk Biol 2003, 73:209-212
15. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interieukin-10 receptor. Annu Rev Immunol 2001, 19:683-765
16. Li Q, Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734
17. Foxwell B, Browne K, Bondeson J, Clarke C, de Martin R, Brennan F, Feldmann M: Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. Proc Natl Acad Sci USA 1998, 95:8211-8215
18. Lake FR, Noble PW, Henson PM, Riches DW: Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons: implications for the pleiotropic activities of TNF alpha. J Clin Invest 199, 93:1661-1669
19. Bhan AK, Schneeberger EE, Collins AB, McCiuskey RT: Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med 1978, 148:246-260
20. Jobin C, Morteau O, Balfour-Sartor R: Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 1998, 95:537-543
21. Kluth DC, Erwig LP, Rees AJ: Gene transfer into inflamed glomeruli using macrophages transfected with adenovirus. Gene Ther 2000, 7:263-270
22. Erwig LP, Kluth DC, Walsh GM, Rees AJ: Initial cytokine exposure determines macrophage function and renders them unresponsive to other cytokines. J Immunol 1998, 161:1983-1988
23. Helfrich MH, Evans DE, Grabowski PS, Pollock JS, Ohshima H, Ralston SH: Expression of nitric oxide synthase isoforms in bone and bone cell cultures. J Bone Miner Res 1997, 12:1108
24. Wang CY, Mayo MW, Baldwin AS: TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996, 274:784-787
25. Lianos EA, Orphanos V, Cattell V, Cook T, Anagnou N: Glomerular expression and cell origin of transforming growth factor-beta 1 in anti-glomerular basement membrane disease. Am J Med Sci 1994, 307:1-5
26. Wilson HM, Minto AW, Brown PAJ, Stewart KN, Rees AJ: Transforming growth factor-beta isoforms and glomerular injury in nephrotoxic nephritis. Kidney Int 2000, 57:2434-2444
27. Bondeson J, Browne K, Brennan F, Foxwell B, Feldman M: Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not Zymosan-induced, pro-inflammatory cytokines are inhibited, but IL-10 is nuclear factor κB independent. J Immunol 1999, 162:2939-2945
28. Kanters E, Gijbels MJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH, de Winther MP: Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 2004, 103:934-940
29. Deb A, Haque SJ, Mogensen T, Silverman RH, Williams BR: RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J Immunol 2001, 166:6170-6180
30. Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BR, Stark GR: Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J 2000, 19:263-272
31. Kumar A, Yang YL, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissmann C, Williams BR: Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J 1997, 16:406-416
32. Alexander WS: Suppressors of cytokine signalling (SOCS) in the immune system Nat Rev Immunol 2002, 2:410-416
33. Kanters E, Pasparakis M, Gijbels MJ, Vergouwe MN, Partouns-Hendriks I, Fijneman RJ, Clausen BE, Forster I, Kockx MM, Rajewsky K, Kraal G, Hofker MH, de Winther MP: Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003, 112:1176-1178
34. Wessells J, Baer M, Young HA, Claudio E, Brown K, Siebenlist U, Johnson PF: BCL-3 and NF-{kappa}B p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J Biol Chem 2004, 279:49995-50003
35. Ikezumi Y, Hurst LA, Masaki T, Atkins RC, Nikolic-Paterson DJ: Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int 2003, 63:83-95
36. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004, 65:116-128
37. Timoshanko JR, Holdsworth SR, Kitching AR, Tipping PG: IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice. J Immunol 2002, 168:4135-4141
38. Timoshanko JR, Sedgwick JD, Holdsworth SR, Tipping PG: Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol 2003, 14:1785-1793
39. Kitching AR, Tipping PG, Holdsworth SR: IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur J Immunol 1999, 29:1-10
40. Minto AW, Erwig LP, Rees AJ: Heterogeneity of macrophage activation in anti-Thy-1.1 nephritis. Am J Pathol 2003, 163:2033-2041
41. Robertson MJ, Erwig LP, Liversidge J, Forrester JV, Rees AJ, Dick AD: Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis. Invest Ophthalmol Vis Sci 2002, 43:2250-2257